Resources


  • values
    Joining Kayentis: Values, mission and vision
    21 November 2017

    Joining Kayentis means also joining a company with… | Read More

  • digital technology and patients tools
    // White paper // Digital Technology and Patients Tools in Clinical Trials – Part 1
    16 October 2017

    Digital technology today has become an important tool… | Read More

  • // White paper // The European Union General Data Protection Regulations
    5 September 2017

    The European Union (EU) Data Protection Regulations (GPDR),… | Read More

  • // Innovation by Kayentis // R&D moves into an ‘Agile’ mode of operation
    18 July 2017

    How the Agile mode, implemented in Kayentis’ R&D… | Read More

  • What can eDiary bring to your study?
    11 July 2017

    During a clinical trial, in particular for late… | Read More

  • ePRO eDiary single device
    Combined ePRO and eDiary: what about using a single device?
    1 July 2017

    Why customers and users choose the Kayentis “Phablet”… | Read More

  • accreditation French Ministry Research
    Accreditation by the French Ministry of Research
    27 June 2017

    ‘We are proud to announce that we have… | Read More

  • Kayentis Infography advantages of eCOA
    Infography: 7 lesser known advantages of eCOA over COA
    25 May 2017

    Advantages of eCOA: Clinical Outcomes Assessment (COA) data… | Read More

  • Case study cardiovascular Kayentis
    Cardiovascular case study: Global Phase III Study – Heart Failure & Actigraphy
    18 May 2017

    After case studies about autoimmune & skin diseases, psoriasis… | Read More

  • Kayentis cloud hosting
    // White paper // Local storage or Cloud hosting?
    11 May 2017

    Over the last 25 years the collection of… | Read More

  • Actigraphy devices: a real impact on clinical research?
    3 May 2017

    Actigraphy has been used in clinical trials for… | Read More

  • ePRO review
    Advantages of direct review of patient-recorded data by clinicians
    6 April 2017

    In ePRO clinical trials, patients may use tablets… | Read More

  • kayentis white paper ecoa vs coa
    //White paper// eCOA vs COA: pros and cons
    23 March 2017

    Electronic tools allow the collection of data (electronic… | Read More

  • Hidden costs of paper ICFs
    9 March 2017

    The past few years have seen a new… | Read More

  • Infography: planning an oncology study with eCOA/ePRO
    21 February 2017

    The FDA has provided guidance on methodology to… | Read More

  • Improve your Risk-based Monitoring with eCOA solutions!
    14 February 2017

    High-frequency on-site monitoring with 100% source data verification… | Read More

  • Data Management: a key factor in data quality
    30 January 2017

    The constant increase in the volume of clinical… | Read More

  • ePRO review
    Kayentis announces a breakthrough feature available in ePRO clinical trials: clinician review of data on a tablet device
    18 January 2017

    It is essential that clinicians review PRO data…. | Read More

  • 12 tips to succeed in your eCOA trial
    15 December 2016

    You have chosen to use an eCOA solution… | Read More

  • eCOA solutions oncology
    eCOA solutions in oncology: What to consider when planning an oncology study with eCOA /ePRO?
    13 December 2016

    The FDA has provided guidance on methodology to… | Read More

Agenda

  • 06 May
    OCT Europe 2020 - May 6-7 - Paris, France - Booth #83 - Schedule a meeting with Kayentis
  • 14 June
    DIA 2020 - June 14-18 - Washington, DC - Booth #239 - Schedule a meeting with Kayentis
  • Follow us

    Download our brochure